StockDriftsStockDriftsHims & Hers Health, Inc. has 6 SEC filings in the last 90 days, latest: CFO Oluyemi Okupe sells 12,313 shares for $354,861 (4, September 18, 2026). Each filing below is summarised from the document itself and links straight to the original on SEC EDGAR.
Of the 6 filings tracked here, 5 report insider sales. See only HIMS Form 4 filings.
Hims & Hers CFO Oluyemi Okupe sold 12,313 Class A shares at $28.82 for $354,861 under a pre-arranged 10b5-1 plan, leaving 251,804 shares directly held.
Hims & Hers Chief Legal Officer Soleil Boughton sold 6,236 Class A shares at $27.86 for $173,734.96 under a pre-arranged 10b5-1 plan.
Chief Operating Officer Michael Chi sold 14,027 Class A shares at $28.39 for $398,226.53 under a pre-arranged 10b5-1 trading plan, leaving him 456,660 shares.
CTO Mohamed Elshenawy sold 7,954 Class A shares at $28.39 for $225,814 under a pre-arranged 10b5-1 plan, leaving him 185,556 shares.
Soleil Boughton, Chief Legal Officer, sold 3,458 shares for a total value of $97,965.14 under a 10b5-1 plan.
Andrew Dudum, CEO, beneficially owns 9.4% of Hims & Hers Health, Inc. Class A Common Stock, as an amendment to a previously filed Schedule 13D.